Skip to main content
. 2019 Mar 23;16:367–377. doi: 10.1016/j.omtn.2019.03.004

Figure 2.

Figure 2

Competition between siRNAs’ Shifted siRNA Potency EC50

(A–C) Dose-response curves for (A) ApoB(19) with or without a competitor siRNA (SSB(291), (B) Apoa4(810) with or without a competitor siRNA Serpina6(1011), and (C) Apoa4(548) with or without a competitor siRNA Serpina6(1011) were measured in Hepa 1-6 cells for ApoB(19) or in primary mouse hepatocytes for Apoa4(810) and Apoa4(548). Data were fit to a sigmoidal dose-response curve; error bars, ±SD, n = 2.